Literature DB >> 10696241

Surgical management of noninvasive bladder cancer (stages Ta/T1/CIS).

J M Holzbeierlein1, J A Smith.   

Abstract

Transurethral removal of bladder cancer is performed for diagnostic and therapeutic reasons. Tissue is returned for histologic determination of tumor grade and stage. For tumors that do not invade the detrusor muscle, resection can be curative although there is a high rate of new tumor occurrence. Surgical removal not only eradicates visible existing lesions but also retrieves material for histologic evaluation. This examination allows a determination of tumor grade as well as stage. Because of the importance of good histologic information in determining prognosis and, possibly, the need for further therapy, the method of surgical removal is important.

Entities:  

Mesh:

Year:  2000        PMID: 10696241     DOI: 10.1016/s0094-0143(05)70230-5

Source DB:  PubMed          Journal:  Urol Clin North Am        ISSN: 0094-0143            Impact factor:   2.241


  4 in total

1.  Best practice in the treatment of nonmuscle invasive bladder cancer.

Authors:  Anastasios Anastasiadis; Theo M de Reijke
Journal:  Ther Adv Urol       Date:  2012-02

Review 2.  Localized bladder cancer.

Authors:  J I Izawa; H B Grossman
Journal:  Curr Treat Options Oncol       Date:  2000-12

3.  Bladder cancer: new TUR techniques.

Authors:  Daniel Wilby; Kay Thomas; Eleanor Ray; Barnaby Chappell; Timothy O'Brien
Journal:  World J Urol       Date:  2009-03-04       Impact factor: 4.226

Review 4.  Management of High-grade T1 Urothelial Carcinoma.

Authors:  Peter A Reisz; Aaron A Laviana; Sam S Chang
Journal:  Curr Urol Rep       Date:  2018-10-26       Impact factor: 3.092

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.